Stock market news for June 16, 2026

Key Points:

• Citi identifies Eli Lilly, Gilead Sciences, and Vertex Pharmaceuticals as top large-cap biopharma stocks, driven by GLP-1 market growth and upcoming product launches. Eli Lilly leads with strong growth due to its market share in key drugs and new oral GLP-1 launch.
• SpaceX, despite being a standout in the tech sector, is considered a unique asset with high revenue expectations, but investors are advised to consider other high-momentum stocks across various sectors.
• Bank of America upgrades Kilroy Realty to buy, citing AI-driven demand boosting rent growth and leasing momentum, despite the stock lagging the broader market in 2026.
• Former Fed member Stephen Miran criticizes the Federal Reserve's focus on backward-looking economic data and urges attention to future inflation risks, ahead of the Fed's upcoming decision expected to maintain current rates.
• China's retail sales declined 0.6% year-over-year in May, marking the first drop in over three years and indicating a deepening economic slump, while industrial output rose 4.5%, and unemployment slightly improved to 5.1%.